These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9201799)

  • 1. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.
    Anton RF; Kranzler HR; McEvoy JP; Moak DH; Bianca R
    Psychopharmacology (Berl); 1997 May; 131(2):123-9. PubMed ID: 9201799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of ethanol withdrawal convulsions in Withdrawal Seizure Prone mice by diazepam and abecarnil.
    Crabbe JC
    Eur J Pharmacol; 1992 Oct; 221(1):85-90. PubMed ID: 1360903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.
    Natolino F; Zanotti A; Contarino A; Lipartiti M; Giusti P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):612-7. PubMed ID: 8938660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.
    Löscher W; Hönack D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):452-60. PubMed ID: 1352384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.
    Rickels K; DeMartinis N; Aufdembrinke B
    J Clin Psychopharmacol; 2000 Feb; 20(1):12-8. PubMed ID: 10653203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.
    Ballenger JC; McDonald S; Noyes R; Rickels K; Sussman N; Woods S; Patin J; Singer J
    Psychopharmacol Bull; 1991; 27(2):171-9. PubMed ID: 1681563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C; Wlaź P; Hönack D; Löscher W
    J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.
    Jung ME; Wallis CJ; Gatch MB; Lal H
    Alcohol; 2000 Jun; 21(2):161-8. PubMed ID: 10963939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.
    Krupitsky EM; Rudenko AA; Burakov AM; Slavina TY; Grinenko AA; Pittman B; Gueorguieva R; Petrakis IL; Zvartau EE; Krystal JH
    Alcohol Clin Exp Res; 2007 Apr; 31(4):604-11. PubMed ID: 17374039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC; McDonald S; Noyes R; Rickels K; Woods SW; Patin J; Lydiard B; Garvey M; Cook B; Goodard AW
    Adv Biochem Psychopharmacol; 1992; 47():431-47. PubMed ID: 1354920
    [No Abstract]   [Full Text] [Related]  

  • 19. Baclofen during alcohol detoxification reduces the need for additional diazepam: a randomized placebo-controlled trial.
    Crunelle CL; Jegham S; Vanderbruggen N; Matthys F
    Alcohol Alcohol; 2023 Sep; 58(5):565-569. PubMed ID: 37526038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.
    Addolorato G; Caputo F; Capristo E; Bernardi M; Stefanini GF; Gasbarrini G
    Clin Neuropharmacol; 1999; 22(1):60-2. PubMed ID: 10047936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.